29.44 +0.55 (1.88%)
DNDN
Stock Details
Last Trade:29.44 Change:+0.55 (1.88%) Prev Close:28.89 Open: 29.22 Days Range:28.95 – 29.51 52 Week Range: 2.55 - 30.90 Volume:1529770 P/E: N/AEPS:-1.84
View AllRecent Alerts 02/09/10
Recent Alert on 02/09/10 at 2:23pm
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
Shares of Dendreon (Nasdaq: DNDN) have ticked higher in the last few minutes of trading as the company's President and CEO, Mitchell Gold, is making some comments at an investor conference in New York. The exec has said that it will have a Provenge... Read More
Recent Alert on 02/09/10 at 2:23pm
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
Recent Alert on 02/09/10 at 2:23pm
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 02/01/10 at 11:35am
Analyst Upgrades, Downgrades and Initiations: ADY, BXP, CYT, DNDN, LZ, ORCL, TWX ...
Analyst Upgrades, Downgrades and Initiations: ADY, BXP, CYT, DNDN, LZ, ORCL, TWX ...
Blog Posts on 01/12/10 at 3:49am
Joe Feshbach's Highest Conviction Position: A Regenerative Medicine 'Game Changer'
Joe Feshbach's Highest Conviction Position: A Regenerative Medicine 'Game Changer'